Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.690
+0.150 (9.74%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pyxis Oncology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 23.71 | 30.83 | 37.35 | 18.66 | 3.85 | 1.66 |
| Research & Development | 56.33 | 49.59 | 86.13 | 51.05 | 9.05 | 1.22 |
| Operating Expenses | 80.04 | 80.42 | 123.48 | 69.72 | 12.89 | 2.88 |
| Operating Income | -64.37 | -80.42 | -123.48 | -69.72 | -12.89 | -2.88 |
| Interest & Investment Income | 7.01 | 6.63 | 2.76 | 0.02 | 0.07 | 0.11 |
| Earnings From Equity Investments | - | - | - | -0.23 | - | - |
| Other Non Operating Income (Expenses) | - | - | - | -6.05 | - | - |
| Pretax Income | -57.36 | -73.79 | -120.72 | -75.98 | -12.83 | -2.77 |
| Net Income | -57.36 | -73.79 | -120.72 | -75.98 | -12.83 | -2.77 |
| Net Income to Common | -57.36 | -73.79 | -120.72 | -75.98 | -12.83 | -2.77 |
| Shares Outstanding (Basic) | 54 | 40 | 33 | 8 | 1 | 1 |
| Shares Outstanding (Diluted) | 54 | 40 | 33 | 8 | 1 | 1 |
| Shares Change (YoY) | 44.74% | 20.80% | 288.93% | 724.14% | 53.40% | - |
| EPS (Basic) | -1.06 | -1.85 | -3.65 | -8.95 | -12.45 | -4.13 |
| EPS (Diluted) | -1.06 | -1.85 | -3.65 | -8.95 | -12.45 | -4.13 |
| Free Cash Flow | -53.87 | -77.44 | -95.73 | -35.87 | -11.57 | -2.24 |
| Free Cash Flow Per Share | -0.99 | -1.94 | -2.90 | -4.22 | -11.22 | -3.33 |
| EBITDA | -61.25 | -78.49 | -122.77 | -69.07 | -12.43 | - |
| D&A For EBITDA | 3.12 | 1.93 | 0.71 | 0.65 | 0.47 | - |
| EBIT | -64.37 | -80.42 | -123.48 | -69.72 | -12.89 | -2.88 |
Source: S&P Capital IQ. Standard template.
Financial Sources.